Abstract
A major bottleneck in gene therapy and DNA vaccination protocols using non viral vectors is the low efficiency of gene transfer. This is mainly attributed to the fact that during the traffic to the target cells nuclei, plasmid vectors must overcome a series of physical, enzymatic and diffusional barriers. The main objective of this work is the development of new multifunctional non-viral …